Faculty Opinions recommendation of Allergen-specific oral immunotherapy for peanut allergy.

2012 ◽  
Author(s):  
John Routes ◽  
James Verbsky
Keyword(s):  
Peanut Allergy ◽  
Oral Immunotherapy

Current management and use of oral immunotherapy in the United States for patients with peanut allergy

2019 ◽  
Vol 40 (4) ◽  
pp. 214-220 ◽  
Author(s):  
Michael S. Blaiss ◽  
Stephen Tilles ◽  
Daniel Petroni ◽  
Ellen Zigmont ◽  
Marie Cassese ◽  
...  
Keyword(s):  
United States ◽  
Peanut Allergy ◽  
The United States ◽  
Oral Immunotherapy ◽  
Current Management

Early Intervention with Oral Immunotherapy is a Promising Strategy for the Treatment of Peanut Allergy

2012 ◽  
Vol 129 (2) ◽  
pp. AB27 ◽  
Author(s):  
B.P. Vickery ◽  
P. Steele ◽  
J. Kamilaris ◽  
A. Edie ◽  
M. Kulis ◽  
...  
Keyword(s):  
Early Intervention ◽  
Peanut Allergy ◽  
Oral Immunotherapy ◽  
Promising Strategy

Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy

2012 ◽  
Vol 129 (2) ◽  
pp. AB140 ◽  
Author(s):  
S.J. Chin ◽  
E.H. Kim ◽  
M.D. Kulis ◽  
P. Varshney ◽  
P. Steele ◽  
...  
Keyword(s):  
Peanut Allergy ◽  
Sublingual Immunotherapy ◽  
Oral Immunotherapy

scholarly journals Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy

2018 ◽  
Vol 9 ◽  
Author(s):  
Benjamin L. Wright ◽  
Nielsen Q. Fernandez-Becker ◽  
Neeraja Kambham ◽  
Natasha Purington ◽  
Dana Tupa ◽  
...  
Keyword(s):  
Peanut Allergy ◽  
Oral Immunotherapy ◽  
Ige Mediated

Investigation of Peanut Oral Immunotherapy Using CpG/Peanut-Nanoparticles in a Murine Model of Peanut Allergy

2015 ◽  
Vol 135 (2) ◽  
pp. AB235 ◽  
Author(s):  
Kamal D. Srivastava ◽  
Alyssa Siefert ◽  
Tarek Fahmy ◽  
Michael J. Caplan ◽  
Xiu-Min Li ◽  
...  
Keyword(s):  
Murine Model ◽  
Peanut Allergy ◽  
Oral Immunotherapy

scholarly journals Comparison of sublingual immunotherapy and oral immunotherapy in peanut allergy

2018 ◽  
Vol 27 (6) ◽  
pp. 153-161 ◽  
Author(s):  
Wenming Zhang ◽  
Sayantani B. Sindher ◽  
Vanitha Sampath ◽  
Kari Nadeau
Keyword(s):  
Peanut Allergy ◽  
Sublingual Immunotherapy ◽  
Oral Immunotherapy

scholarly journals Oral immunotherapy for treatment of peanut allergy

2020 ◽  
Vol 68 (6) ◽  
pp. 1152-1155
Author(s):  
Joan H Dunlop
Keyword(s):  
Food Allergy ◽  
Peanut Allergy ◽  
Food Challenge ◽  
Oral Immunotherapy ◽  
Peanut Protein ◽  
Subcutaneous Immunotherapy ◽  
Double Blind ◽  
The Us ◽  
Allergy Prevalence

The US Food and Drug Administration’s approval of a peanut oral immunotherapy product in January 2020 is a landmark development in the field of food allergy therapy. While food allergy prevalence has been increasing, this product is the first approved therapy for food allergy. Oral immunotherapy has many similarities to subcutaneous immunotherapy and drug desensitization protocols, but does not lead to sustained unresponsiveness. The studies leading to approval of the Palforzia product demonstrated increase in the amount of peanut protein able to be consumed, with 67% of subjects randomized to the treatment arm able to consume 600 mg of peanut protein in double-blind placebo-controlled food challenge at study exit. However, side effects are an important consideration, and dropout rates in studies of Palforzia ranged from 11% to 21%. Postmarketing surveillance of this product will be critical in assessing its long-term risks and benefits.

Sign in / Sign up

Export Citation Format

Share Document